Form EFFECT - Notice of Effectiveness

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Form EFFECT - Notice of Effectiveness

Polyrizon (NASDAQ:PLRZ)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Polyrizon Charts.

Polyrizon (NASDAQ:PLRZ)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Polyrizon Charts.

Polyrizon Ltd News

Form EFFECT - Notice of Effectiveness
Wednesday 15 January 2025 (4 days ago) • Edgar (US Regulatory)

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Friday 10 January 2025 (1 week ago) • Edgar (US Regulatory)

Form F-1 - Registration statement for certain foreign private issuers
Monday 30 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 30 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Polyrizon Announces Publication of U.S. National Patent Application for Its Innovative Hydrogel Nasal Technologies
Monday 30 December 2024 (3 weeks ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 19 December 2024 (1 month ago) • Edgar (US Regulatory)

Polyrizon Appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs
Thursday 19 December 2024 (1 month ago) • GlobeNewswire Inc.

Polyrizon's Moving Forward with Expected 2025 Clinical Trial - Entered Manufacturing Agreement for its PL-14 Allergy Blocker
Wednesday 18 December 2024 (1 month ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 13 December 2024 (1 month ago) • Edgar (US Regulatory)

Polyrizon Announces Appointment of VP of Regulatory Affairs and Quality Assurance
Friday 13 December 2024 (1 month ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 2 December 2024 (2 months ago) • Edgar (US Regulatory)

Polyrizon Enters into GMP Manufacturing Agreement for CTM Supply of its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial
Monday 2 December 2024 (2 months ago) • GlobeNewswire Inc.

More Polyrizon Ltd News Articles

Intergrated Cannabis Sol... (PK)

Decentral Life (PK)

Rennova Health (CE)

Good Vibrations Shoes (PK)

Fannie Mae (QB)

Anavex Life Sciences

Northwest Biotherapeutics (QB)

Lightwave Logic

Elite Pharmaceuticals (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions